In vitro opioid induced proliferation of peripheral blood immune cells correlates with in vivo cold pressor pain tolerance in humans: A biological marker of pain tolerance

Pain

Volumn 110, Issue 3, 2004, Pages 751-755

  Hutchinson, Mark R ^a   La Vincente, Sophie F ^a   Somogyi, Andrew A ^a  

^a UNIVERSITY OF ADELAIDE   (Australia)

Author keywords

Biomarker; Cold pressor pain tolerance; Human; Immune system; Morphine; Nociception; Peripheral blood mononuclear cells

Indexed keywords

BIOLOGICAL MARKER; MORPHINE; OPIATE;

ADULT; ARTICLE; BLOOD; CELL ISOLATION; CELL PROLIFERATION; COLD; COLD PRESSOR TEST; CORRELATION ANALYSIS; FEMALE; HUMAN; IMMUNE SYSTEM; IMMUNOCOMPETENT CELL; INCUBATION TIME; MALE; NOCICEPTION; NOCICEPTIVE STIMULATION; NORMAL HUMAN; PAIN THRESHOLD; PRIORITY JOURNAL; STIMULUS;

ADULT; ANALGESICS, OPIOID; ANALYSIS OF VARIANCE; BIOLOGICAL MARKERS; CELL DIVISION; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HUMANS; LEUKOCYTES, MONONUCLEAR; MALE; MORPHINE; PAIN MEASUREMENT; PAIN THRESHOLD;

EID: 3843143074     PISSN: 03043959     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pain.2004.05.017     Document Type: Article

References (37)

1. Ahmed S.A., Gogal R.M. Jr, Walsh J.E. A new rapid and simple non-radioactive assay to monitor and determine the proliferation of lymphocytes: an alternative to [3H]thymidine incorporation assay. J Immunol Methods. 170:1994;211-224
2. al'Absi M., Petersen K.L., Wittmers L.E. Adrenocortical and hemodynamic predictors of pain perception in men and women. Pain. 96:2002;197-204
3. Boddeke E.W. Involvement of chemokines in pain. Eur J Pharmacol. 429:2001;115-119
4. Cabot P.J., Cater L., Gaiddon C., Zhang Q., Schafer M., Loeffler J.P., Stein C. Immune cell-derived β-endorphin: production, release and control of inflammatory pain in rats. J Clin Invest. 100:1997;142-148
5. De Jalon G., Harrison F.J., Johnson K.I., Kozma C., Schnelle K. A modified cold stimulation technique for the evaluation of analgesic activity in human volunteers. Pain. 22:1985;183-189
6. Dougherty P.M., Aronowski J., Samorajski T., Dafny N. Opiate antinociception is altered by immunemodification: the effect of interferon, cyclosporine and radiation-induced immune suppression upon acute and long-term morphine activity. Brain Res. 385:1986;401-404
7. Dougherty P.M., Pellis N.R., Dafny N. The brain and the immune system: an intact immune system is essential for the manifestation of withdrawal in opiate addicted rats. Neuroscience. 36:1990;285-289
8. Doverty M., Somogyi A.A., White J.M., Bochner F., Beare C.H., Menelaou A., Ling W. Methadone maintenance patients are cross-tolerant to the antinociceptive effects of morphine. Pain. 93:2001;155-163
9. Doverty M., White J.M., Somogyi A.A., Bochner F., Ali R., Ling W. Hyperalgesic responses in methadone maintenance patients. Pain. 90:2001;91-96
10. Glasel J.A. The effects of morphine on cell proliferation. Prog Drug Res. 55:2000;33-80
11. Guarino R., Hemperly J., Darwin A., Timmins M. Novel homogeneous assay system for predictive toxicology screening. IBC Early ADME/Toxicology Conference, New Orleans, LA. 1999
12. Gul H., Yildiz O., Dogrul A., Yesilyurt O., Isimer A. The interaction between IL-1β and morphine: possible mechanism of the deficiency of morphine-induced analgesia in diabetic mice. Pain. 89:2000;39-45
13. Hardy S.D., Wolff H.G., Goodell H. Pain sensations and reactions. 1967;Hafner, New York
14. Holguin A., Johnston I.N., Milligan E.D., Martin D., Maier S.F., Watkins L.R. Spinal pro-inflammatory cytokines modulate morphine analgesia and subsequent development of tolerance, hyperalgesia and allodynia. 2003;Society for Neuroscience, New Orleans
15. Hutchinson M.R., Somogyi A.A. Relationship between 4,5-epoxymorphinan structure and in vitro modulation of cell proliferation. Eur J Pharmacol. 494:2004;251-262
16. Iuvone T., Capasso A., D'Acquisto F., Carnuccio R. Opioids inhibit the induction of nitric oxide synthase in J774 macrophages. Biochem Biophys Res Commun. 212:1995;975-980
17. Jones S.F., McQuay H.J., Moore R.A., Hand C.W. Morphine and ibuprofen compared using the cold pressor test. Pain. 34:1988;117-122
18. Kalso E. Biomarkers for pain. Pain. 107:2004;199-201
19. Kamei J., Kawashima N., Kasuya Y. Role of spleen or spleen products in the deficiency in morphine-induced analgesia in diabetic mice. Brain Res. 576:1992;139-142
20. Kimball E.S., Raffa R.B. Obligatory role of B cells and adherent accessory cells in the transfer of a defect in morphine-mediated antinociception in C57BL/6J-bg/bg (beige-J) mice. J Neuroimmunol. 22:1989;185-192
21. La Vincente S.F., White J.M., Bochner F., Somogyi A.A., Ling W. The antinociceptive responses of opioid-dependent and opioid-naive individuals to experimentally induced pain. College on Problems of Drug Dependence 65th Annual Scientific Meeting, Bal Harbour, Florida. 2003
22. Mannes A.J., Martin B.M., Yang H.Y., Keller J.M., Lewin S., Gaiser R.R., Iadarola M.J. Cystatin C as a cerebrospinal fluid biomarker for pain in humans. Pain. 102:2003;251-256
23. Pampusch M.S., Osinski M.A., Brown D.R., Murtaugh M.P. The porcine mu opioid receptor: molecular cloning and mRNA distribution in lymphoid tissues. J Neuroimmunol. 90:1998;192-198
24. Pampusch M.S., Osinski M.A., Serie J.R., Murtaugh M.P., Brown D.R. Opioid receptor gene expression in the porcine immune system. Adv Exp Med Biol. 437:1998;59-65
25. Pignatti C., Stanic I., Stefanelli C., Tantini B., Rossoni C., Flamigni F. Modulation of the induction of ornithine decarboxylase by some opioid receptor agonists in immune cells and cardiomyocytes. Mol Cell Biochem. 185:1998;47-53
26. Posner J., Telekes A., Crowley D., Phillipson R., Peck A.W. Effects of an opiate on cold-induced pain and the CNS in healthy volunteers. Pain. 23:1985;73-82
27. Raghavendra V., Rutkowski M.D., DeLeo J.A. The role of spinal neuroimmune activation in morphine tolerance/hyperalgesia in neuropathic and sham-operated rats. J Neurosci. 22:2002;9980-9989
28. Rittner H.L., Brack A., Machelska H., Mousa S.A., Bauer M., Schafer M., Stein C. Opioid peptide-expressing leukocytes: identification, recruitment, and simultaneously increasing inhibition of inflammatory pain. Anesthesiology. 95:2001;500-508
29. Roy S., Chapin R.B., Cain K.J., Charboneau R.G., Ramakrishnan S., Barke R.A. Morphine inhibits transcriptional activation of IL-2 in mouse thymocytes. Cell Immunol. 179:1997;1-9
30. Sacerdote P., Bianchi M., Gaspani L., Manfredi B., Maucione A., Terno G., Ammatuna M., Panerai A.E. The effects of tramadol and morphine on immune responses and pain after surgery in cancer patients. Anesth Analg. 90:2000;1411-1414
31. Watkins L.R., Maier S.F., Goehler L.E. Immune activation: the role of pro-inflammatory cytokines in inflammation, illness responses and pathological pain states. Pain. 63:1995;289-302
32. Wolf G., Yirmiya R., Goshen I., Iverfeldt K., Holmlund L., Takeda K., Shavit Y. Impairment of interleukin-1 (IL-1) signalling reduces basal pain sensitivity in mice: genetic, pharmacological and developmental aspects. Pain. 104:2003;471-480
33. Wolff B.B., Kantor T.G., Jarvik M.E., Laska E. Response of experimental pain to analgesic drugs. Clin Pharmacol Ther. 7:1966;224-238
34. Wybran J., Appelboom T., Famaey J.P., Govaerts A. Suggestive evidence for receptors for morphine and methionine-enkephalin on normal human blood T lymphocytes. J Immunol. 123:1979;1068-1070
35. Yaksh T.L. Pharmacology and mechanisms of opioid analgesic activity. Acta Anaesthesiol Scand. 41:1997;94-111
36. Yang H.Y., Wilkening S., Iadarola M.J. Spinal cord genes enriched in rat dorsal horn and induced by noxious stimulation identified by subtraction cloning and differential hybridization. Neuroscience. 103:2001;493-502
37. Zhi-Jun Y., Sriranganathan N., Vaught T., Arastu S.K., Ahmed S.A. A dye-based lymphocyte proliferation assay that permits multiple immunological analyses: mRNA, cytogenetic, apoptosis, and immunophenotyping studies. J Immunol Methods. 210:1997;25-39